Contact information
Nuffield Division of Clinical Laboratory Sciences (NDCLS), John Radcliffe Hospital, Oxford
Daniel Royston
MBChB BMSC DPhil FRCPath
NDS Bioresource Director
- Associate Professor of Pathology
- Academic Pathologist
- Consultant Haematopathologist
I am an academic Haematopathologist holding a joint University and NHS position. I trained in Medicine and Cellular Pathology before completing my DPhil at the University of Oxford in 2011.
The main focus of my research group is the systematic characterisation of the cellular and stromal interactions within biopsy material that drive the initiation and progression of myeloid blood cancers, with specific focus on myeloproliferative neoplasms (MPN).
For more information, please see my full profile.
Recent publications
CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis.
Journal article
Rampotas A. et al, (2026), Sci Transl Med, 18
Accuracy of Diagnosis in Myeloproliferative Neoplasms With Splanchnic Vein Thrombosis (MPN-SVT).
Journal article
Sreedhar BR. et al, (2026), Am J Hematol
Causes of excess non-lymphoma death in 58,000 patients with DLBCL diagnosed during 1997-2020 and followed for up to 25 years.
Journal article
Challenger A. et al, (2026), Blood Adv
Wnt-dependent spatiotemporal reprogramming of bone marrow niches drives fibrosis.
Journal article
Banjanin B. et al, (2026), Hemasphere, 10
Unsupervised Discovery of Spatiotypes and Context-Aware Graph Neural Networks for Modeling Clinical Endpoints
Chapter
Dawood M. et al, (2026), 15970 LNCS, 603 - 612